本文選題：諾舒阻抗控制子宮內(nèi)膜切除系統(tǒng) + 異常子宮出血　； 參考：《中國微創(chuàng)外科雜志》2015年01期

【摘要】：目的探討諾舒(Nova Sure)阻抗控制子宮內(nèi)膜切除系統(tǒng)治療心臟病術(shù)后異常子宮出血(abnormal uterine bleeding,AUB)的臨床療效。方法 2011年6月~2013年1月采用諾舒對15例心臟病術(shù)后AUB行子宮內(nèi)膜去除術(shù),術(shù)前排除子宮內(nèi)膜及宮頸惡性病變,擴張宮頸后先行宮腔鏡檢查,然后將諾舒阻抗控制子宮內(nèi)膜切除系統(tǒng)的雙極消融器送入宮腔,測試通過后行子宮內(nèi)膜去除,再次宮腔鏡檢查,了解子宮內(nèi)膜去除情況。記錄術(shù)前后情況,并進行1、3、6個月隨訪,觀察月經(jīng)情況和并發(fā)癥。結(jié)果 15例術(shù)中生命體征平穩(wěn),手術(shù)順利。血紅蛋白術(shù)前(91.33±21.38)g/L,術(shù)后6個月升高至(113.89±19.32)g/L,有統(tǒng)計學(xué)差異(t=5.640,P=0.000),貧血狀態(tài)明顯好轉(zhuǎn)。1例心功能由Ⅲ級變?yōu)棰蚣?2例心功能由Ⅱ級變?yōu)棰窦?其余患者心功能未見變化。術(shù)后1、3、6個月隨訪15例,治療均有效(參照月經(jīng)改善評價標準),閉經(jīng)率分別為66.7%(10/15)、73.3%(11/15)、80.0%(12/15)。結(jié)論諾舒阻抗子宮內(nèi)膜切除術(shù)治療心臟病術(shù)后AUB療效確切,安全性高。
[Abstract]:Objective to investigate the clinical effect of norsuzolium Nova Sure) Impedance controlled endometrial resection system in the treatment of abnormal uterine bleeding after cardiac surgery.Methods from June 2011 to January 2013, 15 AUB patients with heart disease were treated with endometrial removal from June 2011 to January 2013. Endometrial and cervical malignant lesions were excluded before operation and hysteroscopy was performed after dilatation of cervix.Then, the bipolar ablation device controlled by Noushu impedance was put into the uterine cavity. After the test passed, the endometrium was removed and the endometrium was removed again by hysteroscopy to understand the removal of the endometrium.The data before and after operation were recorded and followed up for 3 months and 6 months to observe menstruation and complications.Results the vital signs of 15 cases were stable and the operation was smooth.Hemoglobin increased from 91.33 鹵21.38 g / L to 113.89 鹵19.32 g / L at 6 months postoperatively, with statistical difference of 5.640g / L. The anemia state was significantly improved from grade 鈪，

本文編號：1758454